The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

2021 ASCO Updates From LIMBER-313 on Myelofibrosis: Parsaclisib + Ruxolitinib for JAKi/PI3Ki Treatment-Naïve Patients

40 views
June 29, 2021
Comments 0
Login to view comments. Click here to Login